Next Oncology Dallas — Irving, Texas

Public research footprint of Next Oncology Dallas, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Advanced Solid Tumor · Breast Cancer · Advanced Solid Tumors

Recently updated registry entries

NCT06445062 — Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors (Recruiting)
NCT07403721 — AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid… (Recruiting)
NCT07493512 — Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Next Oncology Dallas?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.